Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. (Record no. 15229607)

MARC details
000 -LEADER
fixed length control field 02399 a2200649 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514210811.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200412s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0732-183X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2004.02.139
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hudson, Melissa M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20041208
245 00 - TITLE STATEMENT
Title Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Nov 2004
300 ## - PHYSICAL DESCRIPTION
Extent 4541-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child, Preschool
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hodgkin Disease
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Methotrexate
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prednisone
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Procarbazine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vinblastine
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krasin, Matthew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Link, Michael P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Donaldson, Sarah S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Billups, Catherine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Merchant, Thomas E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kun, Larry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Billet, Amy L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaste, Sue
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tarbell, Nancy J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Howard, Scott
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Friedmann, Alison M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hurwitz, Craig A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Young, Jeffrey A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marcus, Karen C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rai, Shesh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cowan, Traci
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weinstein, Howard J
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 22
-- no. 22
-- p. 4541-50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2004.02.139">https://doi.org/10.1200/JCO.2004.02.139</a>
Public note Available from publisher's website

No items available.